Royal Bank of Canada’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-4,266	Closed	-$1K	–	7411
2023 Q1	$1K	Sell	4,266 -7,179	-63%	-$1.68K	﹤0.01%	6603
2022 Q4	$14K	Buy	11,445 +8,525	+292%	+$10.4K	﹤0.01%	5967
2022 Q3	$6K	Buy	2,920 +2,437	+505%	+$5.01K	﹤0.01%	6201
2022 Q2	$1K	Buy	+483	New	+$1K	﹤0.01%	6811